Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

21 May 2025

10.60

-1.40%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, we would like to inform you that the Board of Director in their Meeting held today which was commenced at 05.45 PM and Concluded at 06.15 PM Inter-alia have consider and approved the Following Appointment of Mr. Prathamesh Chalke as Additional Director (Executive Director) and Occupier of All Units of the Company. Further the aforesaid appointment shall be subject to approval of Members at the ensuing General Meeting /Postal Ballot of the Company.

pdf

Lasa Supergenerics Ltd.

19 May 2025

10.60

-1.40%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances

BSE India

Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015, and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 we wish to inform you that a minor fire Incident occurred at our plant Located in Lote Parshuram Industrial Area on 18.05.2025. the Incident resulted in limited damage to certain inventory, machinery and office area.

pdf

Lasa Supergenerics Ltd.

16 May 2025

10.60

-1.40%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for The Quarter And The Year Ended …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 26, 2025, inter alia; 1. To consider, approve and take on records Audited financial results of the Company for the quarter and the year ended March 31, 2025. 2. To discuss any other matter with the permission of the Chairperson.

pdf

Lasa Supergenerics Ltd.

13 May 2025

10.60

-1.40%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

With Reference to the above and in Compliance with Regulation 30 of Listing Regulation, We here by Information you that Mr. Umesh S Pawar (DIN: 10539778) has tendered his Resignation as Whole Time Director of the Company with effect from Closing hour of Tuesday 13th May 2025. Mr. Umesh S Pawar (Din: 10539778) through his resignation letter has also confirmed that there are no other material reason for his resignation other that those provided in his resignation letter date 13th May 2025

pdf

Lasa Supergenerics Ltd.

06 May 2025

10.60

-1.40%

Company Update

Lasa Supergenerics Ltd - 540702 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Pursuant to the Query received from NSE and Regulation 30 of the SEBI (LODR) Regulations, 2015 and the EGM held on Saturday, February 22, 2025

pdf

Lasa Supergenerics Ltd.

24 Apr 2025

10.60

-1.40%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release titled " Lasa Supergenerics Limited Announces the Expansion of Manufacturing Capacity of API Albendazole to meet the growing demand" issued by the Company

pdf

Lasa Supergenerics Ltd.

18 Apr 2025

10.60

-1.40%

Company Update

Lasa Supergenerics Ltd - 540702 - Declaration With Respect To Non- Applicabitlity Of Large Entity

BSE India

Pursuant to SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26 th November , 2018 for fund raising by issuance of debt securities by large entities and compliance thereof

pdf

Lasa Supergenerics Ltd.

18 Apr 2025

10.60

-1.40%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith certificate under regulation 74 (5)of SEBI (Depositories and Participants) Regulations, 2018 for quarter and the year ended March 2025 received from RTA Bigshare Services Private Limited of the Company

pdf

Lasa Supergenerics Ltd.

27 Mar 2025

10.60

-1.40%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to inform you that as per the Company Code of Conduct for Regulating , Monitoring and Reporting of Trading by Insiders in terms of (Prohibiton of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company shall be closed for designated employees and their immediate relatives'' w.e.f April 01, 2025 till 48 hours after the declaration of Audited Financial Results for the quarter and the year ended March 31, 2025

pdf

Lasa Supergenerics Ltd.

04 Mar 2025

10.60

-1.40%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Integrated Filing (Financial)

BSE India

Pursuant to SEBI Circular No. SEBI /HO/CFD/CFD-PoD-2 /CIR/P/2024/185 Dated 31.12.2024, read with BSE circular and NSE circluar dated 02.01.2025. We are submitting herewith the Integrated filing (Financial) for the quarter ended December 31, 2024

pdf

Is Lasa Supergenerics Ltd. worth buying?

52 Votes:

Buy 76.92%

Sell 17.31%

Hold 5.77%